Progeroid disorders are a heterogenous group of rare and complex hereditary syndromes presenting with pleiotropic phenotypes associated with normal aging. Due to the large variation in clinical ...
Nearly 40 per cent of participants in the Phenome India-CSIR Health Cohort could be affected by ...
The Buck Institute for Research on Aging and Phenome Health are joining forces in the quest to understand the biology of aging. Phenome Health, a Seattle-based nonprofit research organization led by ...
The Buck Institute for Research on Aging and strategic partner Phenome Health today announced a four-year award of up to $52M from the Advanced Research Projects Agency for Health (ARPA-H) to support ...
Phenome Health employs a data-driven approach to wellness and disease that integrates diverse types of health data. “Pattern is a pioneer in finding novel patterns in complex data that cannot be ...
Impact of COVID-19 on the stage at diagnosis and mortality of colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...
A study in The Lancet Regional Health Southeast Asia highlights the prevalence of metabolic-dysfunction-associated steatotic liver disease (MASLD) in 40% of participants from the Phenome India-CSIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results